EXTENDED INTERVAL DOSING OF OCRELIZUMAB REDUCES RISK OF DEVELOPING HYPOGAMMAGLOBULINAEMIA

被引：2
|
作者：
Allen, Christopher [1 ]
Russell, Melanie [2 ]
Pendlebury, Jessica [3 ]
Vollmer, Brandi [4 ]
Moswela, Olivia [5 ]
Raza, Pranee-Ta [6 ]
Garjani, Afagh
Abdel-Fahim, Rasha [7 ]
Tallantyre, Emma [8 ]
Evangelou, Nikos [1 ]
机构：
[1] Univ Nottingham, Nottingham, England
[2] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England
[3] Salford Royal NHS Fdn Trust, Salford, Lancs, England
[4] Univ Colorado, Dept Neurol, Boulder, CO USA
[5] Oxford Univ Hosp NHS Fdn Trust, Oxford, England
[6] Cleveland Clin, Cleveland, OH USA
[7] Nottingham Univ Hosp NHS Trust, Nottingham, England
[8] Cardiff Univ, Div Psychol Med & Clin Neurosci, Cardiff, Wales
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2022年 / 93卷 / 09期
关键词：
D O I：
10.1136/jnnp-2022-abn2.26
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Ocrelizumab extended interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience
    Guerrieri, S.
    Nozzolillo, A.
    Zanetta, C.
    Genchi, A.
    Azzimonti, M.
    Gattuso, I.
    Filippi, M.
    Moiola, L.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 846 - 847
  • [32] Efficacy and safety of natalizumab extended interval dosing
    Zeineddine, M.
    Ayyoubi, N.
    Tamim, H.
    Nicolas, J.
    Khoury, S.
    Yamout, B.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 871 - 871
  • [33] Pharmacodynamics of natalizumab extended interval dosing in MS
    Zhovtis Ryerson, Lana
    Li, Xiaochun
    Goldberg, Judith D.
    Hoyt, Tamara
    Christensen, Angel
    Metzger, Ryan R.
    Kister, Ilya
    Foley, John
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (02):
  • [34] An extended interval dosing method for gentamicin in neonates
    Stickland, MD
    Kirkpatrick, CMJ
    Begg, EJ
    Duffull, SB
    Oddie, SJ
    Darlow, BA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (06) : 887 - 893
  • [35] Extended-interval Aminoglycoside Dosing in Pediatrics
    Jenh, Alice M.
    Tamma, Pranita D.
    Milstone, Aaron M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (04) : 338 - 339
  • [36] Efficacy and safety of natalizumab extended interval dosing
    Yamout, Bassem, I
    Sahraian, Mohamad Ali
    El Ayoubi, Nabil
    Tamim, Hani
    Nicolas, Johnny
    Khoury, Samia J.
    Zeineddine, Maya M.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 24 : 113 - 116
  • [37] Efficacy and safety of natalizumab extended interval dosing
    Zeineddine, Maya
    Ayyoubi, Nabil
    Tamim, Hani
    Nicolas, Johny
    Khoury, Samia
    Yamout, Bassem
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP22 - NP23
  • [38] Extended interval dosing of natalizumab in multiple sclerosis
    Ryerson, L. Zhovtis
    Frohman, T. C.
    Foley, J.
    Kister, I.
    Weinstock-Guttman, B.
    Tornatore, C.
    Pandey, K.
    Donnelly, S.
    Pawate, S.
    Bomprezzi, R.
    Smith, D.
    Kolb, C.
    Qureshi, S.
    Okuda, D.
    Kalina, J.
    Rimler, Z.
    Green, R.
    Monson, N.
    Hoyt, T.
    Bradshaw, M.
    Fallon, J.
    Chamot, E.
    Bucello, M.
    Beh, S.
    Cutter, G.
    Major, E.
    Herbert, J.
    Frohman, E. M.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (08): : 885 - 889
  • [39] Extended-interval dosing of natalizumab in NOVA
    Stuve, Olaf
    Tugemann, Bastian
    LANCET NEUROLOGY, 2023, 22 (03): : 199 - 200
  • [40] Extended interval dosing of gentamicin in preterm infants
    Mercado, CK
    Brodsky, NL
    McGuire, MK
    Hurt, H
    AMERICAN JOURNAL OF PERINATOLOGY, 2004, 21 (02) : 73 - 77
12345